Summit Therapeutics
SMMT
#1787
Rank
โ‚ฌ10.07 B
Marketcap
13,54ย โ‚ฌ
Share price
0.31%
Change (1 day)
-24.72%
Change (1 year)

Market capitalization of Summit Therapeutics (SMMT)

Market cap: โ‚ฌ10.07 Billion

As of February 2026 Summit Therapeutics has a market cap of โ‚ฌ10.07 Billion. This makes Summit Therapeutics the world's 1787th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Summit Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ10.07 B-12.31%
2025โ‚ฌ11.49 B-10.92%
2024โ‚ฌ12.90 B679.89%
2023โ‚ฌ1.65 B107.45%
2022โ‚ฌ0.79 B243.67%
2021โ‚ฌ0.23 B-26.16%
2020โ‚ฌ0.31 B227.6%
2019โ‚ฌ95.94 M480.13%
2018โ‚ฌ16.53 M-88%
2017โ‚ฌ0.13 B37.73%
2016โ‚ฌ0.10 B-22.38%
2015โ‚ฌ0.12 B

End of Day market cap according to different sources

On Feb 22nd, 2026 the market cap of Summit Therapeutics was reported to be:

โ‚ฌ10.04 Billion
by Nasdaq info icon info icon
โ‚ฌ10.04 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
โ‚ฌ1.61 B-83.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚ฌ0.18 B-98.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚ฌ0.16 B-98.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
โ‚ฌ5.22 B-48.21%๐Ÿ‡บ๐Ÿ‡ธ USA